WO2003031566A3 - Keratinocyte derived interferon - Google Patents

Keratinocyte derived interferon Download PDF

Info

Publication number
WO2003031566A3
WO2003031566A3 PCT/US2002/023214 US0223214W WO03031566A3 WO 2003031566 A3 WO2003031566 A3 WO 2003031566A3 US 0223214 W US0223214 W US 0223214W WO 03031566 A3 WO03031566 A3 WO 03031566A3
Authority
WO
WIPO (PCT)
Prior art keywords
kdi
methods
interferon
derived interferon
keratinocyte derived
Prior art date
Application number
PCT/US2002/023214
Other languages
French (fr)
Other versions
WO2003031566A2 (en
Inventor
David W Lafleur
Paul A Moore
Steven M Ruben
Original Assignee
Human Genome Sciences Inc
David W Lafleur
Paul A Moore
Steven M Ruben
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/908,594 external-priority patent/US6472512B1/en
Application filed by Human Genome Sciences Inc, David W Lafleur, Paul A Moore, Steven M Ruben filed Critical Human Genome Sciences Inc
Priority to AU2002361550A priority Critical patent/AU2002361550A1/en
Publication of WO2003031566A2 publication Critical patent/WO2003031566A2/en
Publication of WO2003031566A3 publication Critical patent/WO2003031566A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a novel KDI protein which is a member of the interferon family. In particular, isolated nucleic acid molecules are provided encoding a human interferon polypeptide, called 'KDI'. KDI polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of KDI activity. Also provided are therapeutic methods for treating immune system-related disorders.
PCT/US2002/023214 2001-07-20 2002-07-19 Keratinocyte derived interferon WO2003031566A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002361550A AU2002361550A1 (en) 2001-07-20 2002-07-19 Keratinocyte derived interferon

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/908,594 2001-07-20
US09/908,594 US6472512B1 (en) 1998-07-21 2001-07-20 Keratinocyte derived interferon
US33616501P 2001-12-06 2001-12-06
US60/336,165 2001-12-06

Publications (2)

Publication Number Publication Date
WO2003031566A2 WO2003031566A2 (en) 2003-04-17
WO2003031566A3 true WO2003031566A3 (en) 2004-04-22

Family

ID=26990071

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/023214 WO2003031566A2 (en) 2001-07-20 2002-07-19 Keratinocyte derived interferon

Country Status (2)

Country Link
AU (1) AU2002361550A1 (en)
WO (1) WO2003031566A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12835A (en) * 2003-10-29 2006-09-15 Koung Nee Bellet Anne Brigitte Dr Interferon omega against HIV / AIDS, cancer and human and veterinary asthma.
US7367961B2 (en) 2004-09-10 2008-05-06 Depuy Spine, Inc. Intradiscal injection of autologous interferon
PT1871353E (en) * 2005-04-15 2011-03-29 Einstein Coll Med Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy
WO2022261189A1 (en) * 2021-06-09 2022-12-15 Systamedic Inc. Host directed drug combinations for treatment of viral infections

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6433145B1 (en) * 1998-07-21 2002-08-13 Human Genome Sciences, Inc. Keratinocyte derived interferon

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6433145B1 (en) * 1998-07-21 2002-08-13 Human Genome Sciences, Inc. Keratinocyte derived interferon

Also Published As

Publication number Publication date
WO2003031566A2 (en) 2003-04-17
AU2002361550A1 (en) 2003-04-22

Similar Documents

Publication Publication Date Title
EP1015468A4 (en) Follistatin-3
DE69841140D1 (en) INTERLEUKIN-17 RECEPTOR-SIMILAR PROTEIN
WO1998030694A3 (en) TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b)
WO1998031818A3 (en) Tace-like and matrilysin-like polypeptides
WO1998033920A3 (en) Tissue factor pathway inhibitor-3
CA2266439A1 (en) Neutrokine .alpha.
WO1998031806A3 (en) Fc receptors and polypeptides
ATE412740T1 (en) HUMAN ALPHA ENDOKINE
WO2000043493A8 (en) Metalloproteinase adam 22
WO2000067793A8 (en) Death domain containing receptor 4
WO2003031566A3 (en) Keratinocyte derived interferon
DE69841751D1 (en) Chemokin alpha-5
WO1998027932A3 (en) Cerebellum and embryo specific protein
WO2000050620A3 (en) Human endokine alpha and methods of use
PL324518A1 (en) Polypeptide showing affinity to enamel matrix
WO2001032128A3 (en) Human chemokine beta-13
EP0990000A4 (en) Connective tissue growth factor-3
WO2000039136A3 (en) Human brainiac-5
WO2002018622A3 (en) TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b)
WO2002099066A3 (en) 20 human secreted proteins
EP1679372A4 (en) Novel plexin polypeptide, dna encoding the same and use thereof
WO2002057420A3 (en) 50 human secreted proteins
WO2002096355A3 (en) Compositions and methods for adipose abundant protein
EP1439224A3 (en) 67 human secreted proteins
EP1538161A3 (en) 32 human secreted proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP